Locations:
Search IconSearch
April 11, 2019/Neurosciences

Innovative Autism Research Focused on Sleep Techniques and Behavioral Interventions Draws $8M DoD Grants

Pediatric visit

The U.S. Department of Defense has awarded a Cleveland Clinic Children’s researcher two, four-year grants to support innovative clinical trials for young children with autism spectrum disorder.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cynthia Johnson, PhD, Director of Cleveland Clinic Children’s Center for Autism, is principal investigator of both studies.

Evaluating the efficacy of 2 parent-focused programs

The first study, a four-year, $1 million grant directed by Dr. Johnson, will evaluate the efficacy of two parent-focused programs – the Sleep Parent Training program (SPT) and the Parent Educational Program (PEP) – both delivered via the Cleveland Clinic Express Care Online app.

The Sleep Parent Training program is modeled after a behavior parent-training program developed by Johnson. Through this randomized trial, parents are provided practical tools and suggestions for improving the child’s bedtime routine, such as self-soothing techniques. The Parent Educational Program provides useful information about the child’s diagnosis and information about accessing services for the child.

The sleep study will involve 90 patients with autism spectrum disorder between the ages 2 and 7 who have a significant sleep disturbance.

“Both programs will be offered through the Cleveland Clinic Express Care telehealth platform over the span of five sessions, which allows us to reach more families and gives more scheduling flexibility,” Dr. Johnson says. “With this approach, we’ll be able to coach the parents at a time that is convenient for them, such as at dinnertime or right before the bedtime routine.”

This research will build upon a previous NIH-funded pilot study, led by Johnson at the University Of Pittsburgh School of Medicine, that observed favorable sleep outcomes with the behavior parent-training program.

Advertisement

Comparing the effectiveness of EIBI and ABA

In addition to the sleep study, the Department of Defense also has awarded Cleveland Clinic Children’s Center for Autism, and four collaborating institutions nationwide, a four-year, $7 million grant to study the comparative effectiveness of early intensive behavior intervention (EIBI) with less intensive, time-limited, applied behavior analysis (ABA) for young children affected by autism spectrum disorder. Key child and parent outcomes will be compared at three time points during the 24 weeks of intervention, at follow-up and at 5 years of age.

The data coordinating center for this study is the University Of Rochester School Of Medicine. Johnson and her team at Cleveland Clinic Children’s Center for Autism will collaborate with co-investigators at May Institute (Randolph, Mass.), Nationwide Children’s Hospital (Columbus, Ohio), and Vanderbilt University Medical Center (Nashville, Tenn.).

The study plans to recruit a total of 130 children, between the ages of 2 to 5, across the collaborative network, of which 33 will be enrolled at Cleveland Clinic Children’s Center for Autism.

Advertisement

Related Articles

Two people working in a community garden
Rehabilitation: Beyond Recovery, Toward Renewed Participation

Tasked-based therapy improves social connection and quality of life

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor
Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug
Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

Ad